Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Fentanyl + Nitrous Oxide for Pediatric Procedural Sedation
NCT02533908Phase 3Completed
- Sponsor
- Kinderspital Zürich
- Start
- Sep 2015
- Primary completion
- Oct 2017
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fentanyl citrate nasal spray in procedural pain (2 arms), sponsored by Kinderspital Zürich. Primary endpoint: Analgesic efficacy of nitrous oxide 70% versus nitrous oxide 70% combined with fentanyl intranasal using the FLACC score. Started Sep 2015; status: completed.
02
Drugs
fentanyl citrate nasal spray
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT02533908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02533908.